All Stories

  1. Evaluation of a bariatric monitoring pass for primary care physicians
  2. Diabetes Mellitus is Associated with a Higher Relative Risk for Parkinson’s Disease in Women than in Men
  3. Bariatric Surgery Impacts Levels of Serum Lipids during Pregnancy
  4. Response to: ‘Association between osteoporosis and statin therapy: the story continues’ by Burden and Weiler
  5. Evidence that the multiflorine‐derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α 2 ‐adrenoceptors in mice
  6. Response to: ‘The association between osteoporosis and statins therapy’ by Lai
  7. Diagnosis of osteoporosis in statin-treated patients is dose-dependent
  8. Insulin Clearance in Women with a History of Gestational Diabetes Assessed by Mathematical Model Analyses of Intravenous Glucose Tolerance Test
  9. Model-Based Assessment of Sex Differences in Glucose Effectiveness and Its Components
  10. Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the Euro...
  11. Glucose effectiveness and its components in relation to body mass index
  12. Decreased beta-cell function in breastfeeding obese and non-obese women: A prospective observational study
  13. Gestational Diabetes Mellitus (GDM) – Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018)
  14. Sex- and age-related differences of metabolic parameters in impaired glucose metabolism and type 2 diabetes compared to normal glucose tolerance
  15. The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
  16. Sex-specific analysis of haemodialysis prevalence, practices and mortality over time: the Austrian Dialysis Registry from 1965 to 2014
  17. The wave of sweetness and obesity continues
  18. Association between Gestational Weight Gain, Gestational Diabetes Risk, and Obstetric Outcomes: A Randomized Controlled Trial Post Hoc Analysis
  19. Diabetes und Schwangerschaft
  20. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  21. Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects
  22. Job-related meaningfulness moderates the association between over-commitment and emotional exhaustion in nurses
  23. Adiponectin and Leptin at Early Pregnancy: Association to Actual Glucose Disposal and Risk for GDM—A Prospective Cohort Study
  24. Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point
  25. Needle beats pill in gestational diabetes mellitus
  26. Assessment of glucose effectiveness from short IVGTT in individuals with different degrees of glucose tolerance
  27. Management of Pregnant Women after Bariatric Surgery
  28. Sex and Gender Differences in Prevention of Type 2 Diabetes
  29. Cost-effectiveness of healthy eating and/or physical activity promotion in pregnant women at increased risk of gestational diabetes mellitus: economic evaluation alongside the DALI study, a European multicenter randomized controlled trial
  30. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes
  31. Diabetes in pregnancy: a new decade of challenges ahead
  32. Combined Metabolomic Analysis of Plasma and Urine Reveals AHBA, Tryptophan and Serotonin Metabolism as Potential Risk Factors in Gestational Diabetes Mellitus (GDM)
  33. Correlates of poor mental health in early pregnancy in obese European women
  34. Assessment of glucose regulation in pregnancy after gastric bypass surgery
  35. Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients
  36. Is a motivational interviewing based lifestyle intervention for obese pregnant women across Europe implemented as planned? Process evaluation of the DALI study
  37. Sex and gender differences in therapy of type 2 diabetes
  38. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy
  39. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults
  40. Influence of gender, working field and psychosocial factors on the vulnerability for burnout in mental hospital staff: results of an Austrian cross-sectional study
  41. Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
  42. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe
  43. Mann oder Frau: Ist das bei Diabetes relevant?
  44. The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients
  45. Similarities in trabecular hypertrophy with site-specific differences in cortical morphology between men and women with type 2 diabetes mellitus
  46. Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention
  47. Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients
  48. Microvascular function in women with former gestational diabetes: A cohort study
  49. Association Study with 77 SNPs Confirms the Robust Role for the rs10830963/G of MTNR1B Variant and Identifies Two Novel Associations in Gestational Diabetes Mellitus Development
  50. Type 2 Diabetes and Cardiovascular Risk in Women 2016
  51. Effect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study
  52. Increased Proportion of Hematopoietic Stem and Progenitor Cell Population in Cord Blood of Neonates Born to Mothers with Gestational Diabetes Mellitus
  53. Better insight into gender-specific diabetes self-management for more effective diabetes services
  54. Use of statins offsets insulin-related cancer risk
  55. Gestationsdiabetes mellitus (GDM) –Diagnostik, Therapie und Nachsorge ,
  56. Diabetes und Schwangerschaft
  57. Altered glucose profiles and risk for hypoglycaemia during oral glucose tolerance testing in pregnancies after gastric bypass surgery
  58. Wie Gender in die Diabetes-Selbstmanagement-Applikation kommt – ein vielversprechender Weg
  59. Diabetes und Schwangerschaft
  60. To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS
  61. The impact of preconceptional obesity on trajectories of maternal lipids during gestation
  62. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
  63. IADPSG and WHO 2013 Gestational Diabetes Mellitus Criteria Identify Obese Women With Marked Insulin Resistance in Early Pregnancy: Table 1
  64. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study
  65. Migration und Diabetes
  66. Psychische Erkrankungen und Diabetes mellitus
  67. Insulintherapie bei Diabetes mellitus
  68. Geschlechtsspezifische Aspekte für die klinische Praxis bei Prädiabetes und Diabetes mellitus
  69. Gestationsdiabetes (GDM)
  70. Gravidität bei vorbestehendem Diabetes für die Leitlinien für die Praxis (AG Diabetes und Schwangerschaft der ÖDG)
  71. Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen
  72. Diabetische Nierenerkrankung – Update 2016
  73. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2
  74. Initial evidence for the link between activities and health: Associations between a balance of activities, functioning and serum levels of cytokines and C-reactive protein
  75. Brennpunkt Adipositas: what gender has to do with …!
  76. Sexualität bei Übergewicht und Adipositas
  77. Clinical and metabolic characteristics of treated hyperlipidemic patients additionally affected by subclinical hyperglycemia
  78. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
  79. Diabetes mellitus und Schwangerschaft
  80. The Cross-Link between Adipokines, Insulin Resistance and Obesity in Offspring of Diabetic Pregnancies
  81. Cardiometabolic Risk in Hyperlipidemic Men and Women
  82. Beliefs, Barriers, and Preferences of European Overweight Women to Adopt a Healthier Lifestyle in Pregnancy to Minimize Risk of Developing Gestational Diabetes Mellitus: An Explorative Study
  83. Gender Obesity Report – Einfluss von Adipositas auf Reproduktion und Schwangerschaft
  84. Human insulin dynamics in women: a physiologically based model
  85. Gender Awareness bei Medizinstudierenden der Medizinischen Universität Wien. Eine empirische Analyse von Geschlechtersensibilität und Geschlechterstereotypisierungen
  86. Application of Penalized Regression Techniques in Modelling Insulin Sensitivity by Correlated Metabolic Parameters
  87. Gender and heart disease
  88. Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus
  89. Potential of a Sports Club–Based Exercise Program for Improving Physical Activity in Type 2 Diabetes Mellitus
  90. Lactation and appetite-regulating hormones: increased maternal plasma peptide YY concentrations 3–6 months postpartum
  91. Physical activity, depressed mood and pregnancy worries in European obese pregnant women: results from the DALI study
  92. Results From a European Multicenter Randomized Trial of Physical Activity and/or Healthy Eating to Reduce the Risk of Gestational Diabetes Mellitus: The DALI Lifestyle Pilot
  93. Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation
  94. Diabetes in pregnancy outcomes: A systematic review and proposed codification of definitions
  95. To explain the variation of OGTT dynamics by biological mechanisms: a novel approach based on principal components analysis in women with history of GDM
  96. Quantification of Diabetes Comorbidity Risks across Life Using Nation-Wide Big Claims Data
  97. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials
  98. Pathophysiological Characteristics and Effects of Obesity in Women With Early and Late Manifestation of Gestational Diabetes Diagnosed by the International Association of Diabetes and Pregnancy Study Groups Criteria
  99. Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience
  100. Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference
  101. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes
  102. Diabetes mellitus und Schwangerschaft
  103. Type 2 Diabetes and Cardiovascular Risk in Women
  104. Hidden Metabolic Disturbances in Women with Normal Glucose Tolerance Five Years after Gestational Diabetes
  105. Iodine deficiency in pregnant women in Austria
  106. Sex-specific differences in diabetes prevention: a systematic review and meta-analysis
  107. No Evidence of Ectopic Lipid Accumulation in the Pathophysiology of the Acromegalic Cardiomyopathy
  108. Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
  109. Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus
  110. Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
  111. Gendermedizin
  112. Gestational Diabetes Mellitus (GDM) Diagnosis, Therapy and Follow-Up Care
  113. Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
  114. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus?
  115. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals
  116. Hepatic Rather Than Cardiac Steatosis Relates to Glucose Intolerance in Women with Prior Gestational Diabetes
  117. Predicting the Metabolic Condition After Gestational Diabetes Mellitus from Oral Glucose Tolerance Test Curves Shape
  118. Diabetes in Hyperparathyroidism
  119. Gestational diabetes mellitus and cardiovascular risk after pregnancy
  120. Effect of Fetal and Infant Malnutrition on Metabolism in Older Age
  121. Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing
  122. Typ-1-Diabetes
  123. Development of a new occupational balance-questionnaire: incorporating the perspectives of patients and healthy people in the design of a self-reported occupational balance outcome instrument
  124. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma
  125. Diabetologie kompakt
  126. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer
  127. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer
  128. Lower Fasting Muscle Mitochondrial Activity Relates to Hepatic Steatosis in Humans
  129. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy
  130. DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial – study protocol
  131. Analysis of Intravenous Glucose Tolerance Test Data Using Parametric and Nonparametric Modeling: Application to a Population at Risk for Diabetes
  132. Geschlechtsspezifische Unterschiede der Endokrinologie im Alter
  133. Reply to Klitz and Niklasson: Can viral infections explain the cross-sectional Austrian diabetes data?
  134. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century
  135. Relationship of pentraxin 3 with insulin sensitivity in gestational diabetes
  136. Nur „der kleine Unterschied“?
  137. Concentration of Free Amino Acids in Human Milk of Women with Gestational Diabetes Mellitus and Healthy Women
  138. Estimating the risk after gestational diabetes mellitus: can we improve the information from the postpartum OGTT?
  139. Lipoprotein(a) is not related to markers of insulin resistance in pregnancy
  140. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study
  141. The impact of recurrent gestational diabetes on maternal metabolic and cardiovascular risk factors
  142. Migration und Diabetes
  143. Positionspapier: Psychische Erkrankungen und Diabetes mellitus
  144. Insulintherapie bei Diabetes mellitus
  145. Geschlechtsspezifische Aspekte für die klinische Praxis bei Prädiabetes und Diabetes mellitus
  146. Gravidität bei vorbestehendem Diabetes für die Leitlinien für die Praxis (AG Diabetes und Schwangerschaft der ÖDG)
  147. Gestationsdiabetes (GDM)
  148. Leitlinien Insulinpumpentherapie bei Kindern und Erwachsenen (Für den Ausschuss Insulinpumpentherapie der Österreichischen Diabetesgesellschaft)
  149. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2
  150. Diabetische Nephropathie – Update 2012
  151. Retinal white blood cell flux and systemic blood pressure in patients with type 1 diabetes
  152. Progression to Type 2 Diabetes in Women with Former Gestational Diabetes: Time Trajectories of Metabolic Parameters
  153. Sex-specific differences in long-term glycemic control and cardiometabolic parameters in patients with type 1 diabetes treated at a tertiary care centre
  154. A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus
  155. Obesity and Diabetes
  156. Adrenal Disorders
  157. Thyroid Disorders
  158. Challenges of Work–Life Balance for Women Physicians/Mothers Working in Leadership Positions
  159. CTX (Crosslaps) Rather than Osteopontin Is Associated with Disturbed Glucose Metabolism in Gestational Diabetes
  160. Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus
  161. Circulating progranulin levels in women with gestational diabetes mellitus and healthy controls during and after pregnancy
  162. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review
  163. Associations of Body Mass Index (Maternal BMI) and Gestational Diabetes Mellitus with Neonatal and Maternal Pregnancy Outcomes in a Multicentre European Database (Diabetes and Pregnancy Vitamin D and Lifestyle Intervention for Gestational Diabetes Mel...
  164. Diabetic Polyneuropathy Relates to Bone Metabolism and Markers of Bone Turnover in Elderly Patients With Type 2 Diabetes: Greater Effects in Male Patients
  165. Women show a closer association between educational level and hypertension or diabetes mellitus than males: a secondary analysis from the Austrian HIS
  166. Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria
  167. Transcription factor 7-like 2 gene polymorphisms and gestational diabetes mellitus
  168. Levels of fetuin-A relate to the levels of bone turnover biomarkers in male and female patients with type 2 diabetes
  169. Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease
  170. Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models
  171. Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes
  172. Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes
  173. Influence of Increasing BMI on Insulin Sensitivity and Secretion in Normotolerant Men and Women of a Wide Age Span
  174. Characterization of Former Gestational Diabetes Mellitus: Prognostic, Therapeutic, and Predictive Aspects
  175. The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome
  176. Fetuin-A Characteristics during and after Pregnancy: Result from a Case Control Pilot Study
  177. Incretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery
  178. Gestational Diabetes Prediction Score (GPS): Eine kosteneffektive Möglichkeit zur Vorhersage von Gestationsdiabetes bei Schwangerschaften mit normalem Nüchternblutzucker
  179. Sex and Gender Differences in Endocrinology
  180. Diabetes und Schwangerschaft
  181. Impact of diabetes mellitus and gender on exercise-related antiangiogenic endostatin/collagen XVIII release
  182. Influence of age, smoking and T2 diabetes on exercise related antiangiogenic endostatin/collagen XVIII release in men
  183. Diabetes und Schwangerschaft
  184. Gestationsdiabetes mellitus (GDM)
  185. Gestationsdiabetes mellitus (GDM) - Diagnostik, Therapie u. Nachsorge
  186. Admission Proinsulin Is Associated with Mortality in Patients with Admission Hyperglycemia during Acute Coronary Syndrome: Results from a Pilot Observational Study
  187. Skeletal Muscle Phosphodiester Content Relates to Body Mass and Glycemic Control
  188. Early Possible Risk Factors for Overt Diabetes After Gestational Diabetes Mellitus
  189. Recruitment of patients with type 2 diabetes for target group specific exercise programs at an Outpatient Department of a Medical University: A factor analysis
  190. Glucose Absorption in Gestational Diabetes Mellitus During an Oral Glucose Tolerance Test
  191. Insulin resistance is not associated with myocardial steatosis in women
  192. Relations of Adiponectin to Levels of Metabolic Parameters and Sexual Hormones in Elderly Type 2 Diabetic Patients
  193. Clinical characteristics, modalities and complications of diabetic patients with migration background at a Central European University Clinic
  194. Editorial: Sex- and gender-based medicine: a challenging field of research
  195. Health behaviour and attitude towards screening examinations in an Austrian urban and rural population: gender aspects – screening and sex
  196. Identification of a model of non-esterified fatty acids dynamics through genetic algorithms: The case of women with a history of gestational diabetes
  197. Perspectives on gender-specific medicine, course and learning style preferences in medical education: a study among students at the Medical University of Vienna
  198. Mechanism and Effects of Glucose Absorption during an Oral Glucose Tolerance Test Among Females and Males
  199. Risk Factor Profile and Pregnancy Outcome in Women with Type 1 and Type 2 Diabetes Mellitus
  200. Coverage of recommended vaccinations in subjects with diabetes mellitus and ischemic heart disease: results for women and men
  201. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance?
  202. Diabetes mellitus und Schwangerschaft
  203. N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
  204. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study
  205. Plasma neuropeptide Y levels differ in distinct diabetic conditions
  206. Sex-Specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus
  207. Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus
  208. Body and Liver Fat Mass Rather Than Muscle Mitochondrial Function Determine Glucose Metabolism in Women With a History of Gestational Diabetes Mellitus
  209. Diabetes und Schwangerschaft
  210. Retinal Blood Flow in Type 1 Diabetic Patients With No or Mild Diabetic Retinopathy During Euglycemic Clamp
  211. Changes in Serum Lipid Levels During Pregnancy in Type 1 and Type 2 Diabetic Subjects
  212. Cross-sectional survey on thyroideal and gonadal hormones in adult patients with high-grade gliomas.
  213. Acht-wöchiges Bewegungsprogramm für Diabetiker verändert nachhaltig deren körperliche Aktivität
  214. Herzfunktion und myocardialer Lipidgehalt bei Frauen nach Gestationsdiabetes
  215. Science & gender: vision and mission
  216. Retinol-Binding Protein 4 in Patients with Gestational Diabetes Mellitus
  217. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
  218. Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus
  219. Diabetes mellitus – Leitlinien für die Praxis
  220. Osteocalcin Is Related to Enhanced Insulin Secretion in Gestational Diabetes Mellitus
  221. Metabolic diseases and associated complications: sex and gender matter!
  222. Serum Vaspin Concentrations in Relation to Insulin Sensitivity Following RYGB-Induced Weight Loss
  223. TCF7L2– Polymorphismen und Gestationsdiabetes
  224. Faktorenanalyse bei Patienten mit Diabetes mellitus, die den Teilnahmewunsch an einem medizinischen Trainingsprogramm beeinflussen
  225. Veränderungen der körperlichen Aktivität im 6 Monate Follow-up in Folge eines 8-wöchigen Bewegungsprogramms
  226. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH)
  227. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes
  228. Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance
  229. Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes
  230. The Impact of Risk Factors and More Stringent Diagnostic Criteria of Gestational Diabetes on Outcomes in Central European Women
  231. Retinol – bindendes Protein 4 bei Patientinnen mit Gestationsdiabetes
  232. Diabetes und Schwangerschaft
  233. Insulin resistance has no impact on ghrelin suppression in pregnancy
  234. Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes
  235. Diabetes mellitus – Leitlinien für die Praxis
  236. Diabetes und Schwangerschaft
  237. Visfatin Response to Glucose Is Reduced in Women With Gestational Diabetes Mellitus
  238. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus
  239. Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimation
  240. Impaired cardiac autonomic function in women with prior gestational diabetes mellitus
  241. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione
  242. Insulinogenic indices from insulin and C-peptide: Comparison of beta-cell function from OGTT and IVGTT
  243. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes
  244. Impaired beta-cell function in lean normotolerant former gestational diabetic women
  245. Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester
  246. Sind "Designer"-Insuline die "besseren" Insuline?
  247. Severe diabetic fetopathy despite strict metabolic control
  248. Large-for-gestational-age newborns in women with insulin-treated gestational diabetes under strict metabolic control
  249. Endocrine Changes in Diabetic Pregnancy
  250. Fetal Hyperinsulinism and Maternal One-Hour Postload Plasma Glucose Level
  251. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus
  252. Haptoglobin Phenotype and Gestational Diabetes
  253. 40th EASD Annual Meeting of the European Association for the Study of Diabetes
  254. Diabetes in der Schwangerschaft
  255. Diabetes in der Praxis
  256. Gestational Diabetes
  257. Mode of action of ipomoea batatas (caiapo) in type 2 diabetic patients
  258. Basal and dynamic proinsulin-insulin relationship to assess β-cell function during OGTT in metabolic disorders
  259. Diabetes-Screening in der Schwangerschaft
  260. Increased Intramyocellular Lipid Concentration Identifies Impaired Glucose Metabolism in Women With Previous Gestational Diabetes
  261. Circulating concentrations of asymmetrical dimethyl- L -arginine are increased in women with previous gestational diabetes
  262. Ocular hyperperfusion following onset of intensified insulin therapy is inversely correlated with plasma endothelin-1 in Type I diabetes
  263. Increased plasma leptin in gestational diabetes
  264. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy
  265. Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men
  266. 35th Annual Meeting of the European Association for the Study of Diabetes
  267. Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment
  268. Ectopic thyroid gland simulating a submandibular tumor
  269. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
  270. Persistent Elevation and Metabolic Dependence of Circulating E-Selectin after Delivery in Women with Gestational Diabetes Mellitus
  271. Persistent Elevation and Metabolic Dependence of Circulating E-Selectin after Delivery in Women with Gestational Diabetes Mellitus
  272. Pronounced Insulin Resistance and Inadequate  -cell Secretion Characterize Lean Gestational Diabetes During and After Pregnancy
  273. Amylin: History and Overview
  274. Amylin Release During Oral Glucose Tolerance Test
  275. Elevated Islet Amyloid Pancreatic Polypeptide and Proinsulin in Lean Gestational Diabetes
  276. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes
  277. β-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects
  278. Integrated mathematical model to assess beta-cell activity during the oral glucose test
  279. Intravenous calcitriol normalizes insulin sensitivity in uremic patients
  280. Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study
  281. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
  282. Role of islet amyloid polypeptide secretion in insulin-resistant humans
  283. Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria
  284. Hormonal and blood glucose responsiveness as an indicator of specific emotional arousal in type 1 diabetics
  285. Elevated hepatic insulin extraction in essential hypertension
  286. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans
  287. Colour doppler imaging of partial subclavian steal syndrome
  288. β-Cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects
  289. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery
  290. Laboratory monitoring of thromboprophylaxis with low molecular weight and standard heparin
  291. Insulin Sensitivity, Secretion and Hepatic Extraction in Untreated Hypertensive Patients